The 33 most recent market catalysts affecting $GEHC, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 18, 2026
Corporate Catalyst
Bullish
Impact 55
BTIG Adjusts Price Target on GE HealthCare Technologies to $91 From $83
Investment firm BTIG has raised its price target for GE HealthCare Technologies (GEHC) from $83 to $91. This upward revision indicates that BTIG has a more favorable view of GEHC's…
Nov 17, 2026
Corporate Catalyst
Bullish
Impact 65
GE HealthCare Receives FDA 510(k) Clearance for Critical Care Suite 3.0
GE HealthCare announced FDA 510(k) clearance for its Critical Care Suite 3.0, an AI-powered software that automatically detects feeding tubes on X-ray images. This is significant a…
Nov 16, 2026
Corporate Catalyst
Bullish
Impact 55
GE HealthCare Expands Global Research Collaborations for Photonova Spectra Photon-Counting CT
GE HealthCare is expanding its global research collaborations for its Photonova Spectra photon-counting CT system. This move is significant as it indicates the company's commitment…
Nov 11, 2026
Corporate Catalyst
Bullish
Impact 55
Argus Adjusts Price Target on GE HealthCare Technologies to $110 From $85
Argus Research updated its valuation analysis for GE HealthCare Technologies, leading to a significant increase in its price target from $85 to $110. This analyst upgrade signals a…
Nov 9, 2026
Corporate Catalyst
Bullish
Impact 55
UBS Raises Price Target on GE Healthcare Technologies
UBS raised its price target on GE Healthcare Technologies (GEHC) from $73 to $80, maintaining a Neutral rating. This upward revision is directly linked to GEHC's recent announcemen…
Nov 5, 2026
Corporate Catalyst
Bearish
Impact 65
GE HealthCare Chief Science and Technology Officer Taha Kass-Hout to Resign
GE HealthCare Technologies Inc. has disclosed that its Chief Science and Technology Officer, Taha Kass-Hout, will resign. This departure is significant as it involves a key leaders…
Nov 4, 2026
Corporate Catalyst
Bullish
Impact 55
GE HealthCare Introduces Photonova Spectra CT System in Greece
GE HealthCare announced the introduction of its Photonova Spectra CT system in Greece, a next-generation photon-counting CT system. This event is significant as it marks the commer…
Nov 3, 2026
Corporate Catalyst
Bullish
Impact 55
UBS Adjusts Price Target on GE HealthCare Technologies to $80
UBS has adjusted its price target for GE HealthCare Technologies (GEHC) upwards to $80, a 9.6% increase from its previous $73 target. Despite this increase, the firm maintained its…
Oct 28, 2026
Corporate Catalyst
Bullish
Impact 92
GE HealthCare Reports Q3 2026 Financial Results and Raises Full-Year Outlook
GE HealthCare announced impressive third-quarter 2026 financial results, exceeding analyst expectations for both revenue and adjusted EPS. This strong performance led the company t…
Oct 7, 2026
Corporate Catalyst
Neutral
Impact 55
Barclays Initiates Coverage On GE HealthCare Techs with Overweight Rating, Announces Price Target of $85
Barclays analyst Christopher Pasquale has initiated coverage on GE HealthCare Technologies (GEHC) with an 'Overweight' rating and an $85 price target. This is a positive developmen…
Oct 5, 2026
Corporate Catalyst
Bearish
Impact 55
Citigroup Maintains Neutral on GE HealthCare Techs, Lowers Price Target to $71
Citigroup analyst Joanne Wuensch has reduced her price target for GE HealthCare Technologies (GEHC) from $75 to $71, while keeping a 'Neutral' rating on the stock. This change indi…
Oct 5, 2026
Corporate Catalyst
Neutral
Impact 92
'GE HealthCare to Buy Sofie for Nearly $1 Billion to Grow Medical-Imaging Business' - WSJ Exclusive
GE HealthCare announced its intention to acquire Sofie Biosciences for nearly $1 billion, as reported by the WSJ. This acquisition is a significant strategic move for GEHC, aiming …
Sep 22, 2026
Corporate Catalyst
Bullish
Impact 55
GE HealthCare Technologies Increases Quarterly Dividend From $0.035 To $0.04 Per Share
GE HealthCare Technologies' Board of Directors declared an increase in its quarterly cash dividend to $0.04 per share, up 14% from the previous quarter. This action is a positive s…
Sep 22, 2026
Corporate Catalyst
Neutral
Impact 55
Needham Initiates Coverage On GE HealthCare Techs with Buy Rating, Announces Price Target of $93
Needham analyst David Saxon has initiated coverage on GE HealthCare Technologies (GEHC) with a 'Buy' rating and a price target of $93. This new analyst coverage is a positive devel…
Sep 14, 2026
Corporate Catalyst
Neutral
Impact 75
'GE HealthCare In Talks Over $1bn Deal For Maker of Cancer Scan Chemicals' - FT
The 8-K filing itself is extremely light, containing only a link to a Financial Times article. This article reports that GE HealthCare is in discussions for a $1 billion acquisitio…
Sep 13, 2026
Corporate Catalyst
Bearish
Impact 85
GE Healthcare in Talks To Acquire Sofie Biosciences, Maker of Cancer Scan Chemicals
GE Healthcare (GEHC) is reportedly pursuing a $1 billion acquisition of Sofie Biosciences, a maker of radioactive chemicals for cancer scans. This move is significant as it represe…
Sep 8, 2026
Corporate Catalyst
Neutral
Impact 65
GE HealthCare Says StarGuide GX 4D CZT SPECT/CT System Is 510(k) Pending With FDA Following CE Mark
This headline indicates a positive step for GE HealthCare as their StarGuide GX system moves closer to US market availability. The CE Mark signifies European regulatory approval, a…
Aug 31, 2026
Corporate Catalyst
Neutral
Impact 75
GE HealthCare Says Photonova Spectra Photon-Counting CT System Received CE Mark; Begins Commercial Activities In CE Mark-Observing Countries
The CE Mark approval for GE HealthCare's Photonova Spectra Photon-Counting CT System is a direct positive catalyst for GEHC, enabling commercialization in a major market. This intr…
Aug 21, 2026
Corporate Catalyst
Neutral
Impact 65
FDA Announces GE Healthcare Issues Early Alert For Portrait Core Services Software Issue
The FDA's early alert for GE Healthcare's Portrait Core Services software issue signals a potential product defect that could cause monitoring interruptions for patients. This is s…
Aug 18, 2026
Corporate Catalyst
Neutral
Impact 55
GE HealthCare Appoints William Grogan CFO, Effective Sept. 14, Succeeding Jay Saccaro
GE HealthCare has appointed William Grogan as its new CFO, effective September 14, 2026. This announcement provides a definitive successor to Jay Saccaro, who left for an external …
Aug 17, 2026
Corporate Catalyst
Bullish
Impact 65
Nelson Peltz Is Now Betting on Both Sides of GE's Breakup
Nelson Peltz's Trian Fund Management, a prominent activist investor, has dramatically increased its holding in GE HealthCare (GEHC) from a negligible amount to nearly $197.5 millio…
Aug 12, 2026
Corporate Catalyst
Bullish
Impact 55
Trian Fund Management, L.P. Raises Share Stake In GE Healthcare Technologies INC. To 3.1M Shares; Cuts Share Stake In Invesco By 45.3% To 1.6M Shares; Change In Holdings Are As Of June 30, 2026, And Compared With The Previous Quarter Ended As Of March 31, 2026
Trian Fund Management, a prominent activist investor, has disclosed its updated holdings as of June 30, 2026. The key changes include a substantial increase in its stake in GE Heal…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 55
GE HealthCare Launches Invenia ABUS Prime And ABUS StreamVue, Expanding Breast Imaging Portfolio With Solutions To Support Supplemental Screening For Women
GE HealthCare announced the launch of Invenia ABUS Prime and ABUS StreamVue, new solutions designed to enhance supplemental breast cancer screening, particularly for women with den…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 65
Wells Fargo Maintains Overweight on GE HealthCare Techs, Raises Price Target to $85
Wells Fargo analyst Larry Biegelsen maintained an 'Overweight' rating on GE HealthCare Technologies and raised the price target from $75 to $85. This upgrade in the price target in…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 55
BTIG Maintains Buy on GE HealthCare Techs, Raises Price Target to $79
BTIG analyst Ryan Zimmerman maintained a 'Buy' rating on GE HealthCare Technologies and raised the price target from $75 to $79. This action signals a positive outlook from a promi…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 92
GE HealthCare Hits Record Backlog, Stock Jumps
GE HealthCare Technologies Inc. (GEHC) announced second-quarter results that exceeded Wall Street expectations, driven by strong performance in its imaging and pharmaceutical diagn…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 75
GE HealthCare Technologies shares are trading higher after the company reported better-than-expected Q2 financial results.
This headline represents a significant corporate catalyst for GE HealthCare Technologies (GEHC). Better-than-expected earnings and revenue typically signal strong operational execu…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 92
GE HealthCare Techs Q2 Adj. EPS $1.13 Beats $1.03 Estimate, Sales $5.295B Beat $5.264B Estimate
GE HealthCare Technologies (GEHC) announced Q2 adjusted EPS of $1.13, significantly beating the $1.03 estimate, and sales of $5.295 billion, also exceeding the $5.264 billion estim…
Jul 16, 2026
Corporate Catalyst
Bearish
Impact 55
UBS Maintains Neutral on GE HealthCare Techs, Lowers Price Target to $67
UBS analyst Graham Doyle maintained a 'Neutral' rating on GE HealthCare Technologies (GEHC) but lowered the price target from $69 to $67. This action indicates a slightly reduced v…
Jul 16, 2026
Corporate Catalyst
Bullish
Impact 55
Catholic Health And GE HealthCare Announce $500M, 10-Year Care Alliance To Expand Patient Access Across Long Island
GE HealthCare and Catholic Health have entered into a substantial $500 million, 10-year care alliance. This agreement is a significant win for GE HealthCare, securing a long-term r…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.